Maike Stegen

Mrs. Maike Stegen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMaike Stegen
Maike Stegen
Ulrich FreyUlrich Frey
Ulrich Frey
The G protein-coupled receptor kinase 6 is associated with inflammation and pathological pain. Impairment of GRK6 expression was described in chronic inflammatory diseases such as rheumatoid arthritis and this was shown to be accompanied by an imbalance of downstream signaling pathways. Here, we discuss novel aspects of GRK6 interaction and its impact upon hyperalgesia and inflammatory processes. In this review, we compile important findings concerning GRK6 regulation for a better pathophysiological understanding of the intracellular interaction in the context of inflammation and show clinical implications—for example, the identification of possible therapy goals in the treatment of chronic inflammatory hyperalgesia.

29 July 2024 in European Journal of Anaesthesiology Intensive Care
Verified
Journal Article
Open access
MSMaike Stegen
Maike Stegen
HBHagen S. Bachmann
Hagen S. Bachmann
GBGrazina Belani
Grazina Belani
AMAhmed Mohamed
Ahmed Mohamed
BBBjörn Breuing
Björn Breuing
SKStefanie Klenke
Stefanie Klenke
BACKGROUND: Postoperative nausea and vomiting (PONV) are the most frequent complications in the context of anaesthesia. Several studies suggest a contribution of genetic traits to PONV disposition. Single nucleotide polymorphisms (SNPs) located in the cholinergic receptor muscarinic 3 gene CHRM3 (rs2165870) and the potassium voltage-gated channel subfamily B member 2 KCNB2 (rs349358) have been described as independent risk factors for the occurrence of PONV. In addition, further SNPs might be associated with an increased PONV risk, for example a dopamine D2 receptor (DRD2) SNP (rs1800497). OBJECTIVE: The primary aim of our study was the development of a new PONV prediction score which includes genetic information of SNPs in the genes CHRM3 and KCNB2, which have been already associated with PONV. The secondary aim of our study was to investigate the association of five additional SNPs with PONV. DESIGN: Prospective cohort study. SETTING: Single centre study in Germany. RESULTS: We could not establish a new PONV prediction score that includes genetic information, due to limited association of the KCNB2 SNP and CHRM3 SNP with PONV. Interestingly, the GA and AA genotypes of the DRD2 rs1800497 in the dopamine D2 receptor gene were associated with PONV 24 h postoperatively, with a relative risk (RR) of GA/AA genotype vs. GG genotype of 1.5 [95% confidence interval (CI) 1.06 to 2.01, P = 0.02]. This association was independent from the Apfel score in a multivariate logistic regression analysis (RR 1.4, 95% CI 1.03 to 1.90, P = 0.03). CONCLUSION: The construction of a new PONV prediction score including genetic information was not possible due to limited association of the CHRM3 and KCNB2 SNPs. However, the DRD2 GA and AA genotypes (rs1800497) were associated with PONV and this SNP might be a future candidate for further validation studies aiming for molecular-derived PONV prediction models. TRIAL REGISTRATION: German Clinical Study Register – DRKS00021051.

18 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMaike Stegen
Maike Stegen
AEAndrea Engler
Andrea Engler
COCrista Ochsenfarth
Crista Ochsenfarth
IMIris Manthey
Iris Manthey
JPJürgen Peters
Jürgen Peters
Ulrich FreyUlrich Frey
Ulrich Frey
Background: G protein-coupled receptor kinase 6 (GRK6) is part of the G protein-coupled receptor kinase family, whose members act as key regulators of seven-transmembrane receptor signalling. GRK6 seems to play a role in regulation of inflammatory processes, but mechanisms of transcriptional regulation of GRK6 expression in inflammatory cell lines have not been characterized. Protein kinase C (PKC) signalling is also involved in inflammatory regulation and an impact of PKC activation on GRK6 protein expression was described previously. Thus, the aim of this study was to 1) characterize theGRK6promoter, and 2) investigate a potential influence of PKC on GRK6 expression.Methods: Five deletion constructs of theGRK6promoter were cloned. After transient transfection into a human T cell line, promoter activity was assessed using luciferase reporter gene assays. Putative transcription factor binding sites were identified, mutated, and binding was investigated using electrophoretic mobility shift assays (EMSA). Following stimulation with a PKC activator, GRK6 expression on mRNA and protein levels was assessed by reverse transcriptase qPCR and Western blots.Results: Investigation of theGRK6promoter revealed a putative cAMP responsive element (CRE), whose mutation led to decreased promoter activity (p = 0.0006). Functionality of the CRE binding protein (CREB) binding site was verified in EMSA blots. Stimulation with a PKC activator resulted in decreasedGRK6promoter activity (p = 0.0027), mRNA (p = 0.04) and protein expression.Conclusion: We characterized the humanGRK6promoter and identified promoter activity to be influenced by a CREB binding site. PKC might be one determinant contributing to altered GRK6 expression.

30 January 2026 in Die Anaesthesiologie
Verified
Journal Article
Closed access
PDF file
MSMaike Stegen
Maike Stegen
CNCeline Nowak
Celine Nowak
TBThorsten Brenner
Thorsten Brenner
SKStefanie Klenke
Stefanie Klenke

1 June 2026 in Die Anaesthesiologie
Verified
Journal Article
Closed access
PDF file
MSMaike Stegen
Maike Stegen
CNCeline Nowak
Celine Nowak
TBThorsten Brenner
Thorsten Brenner
SKStefanie Klenke
Stefanie Klenke

10 October 2025 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
HBHagen S. Bachmann
Hagen S. Bachmann
MSMaike Stegen
Maike Stegen
DJDominik Jung
Dominik Jung
LWLea Weber
Lea Weber
TBThorsten Brenner
Thorsten Brenner
SKStefanie Klenke
Stefanie Klenke